Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251). (Q45399692)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 September 2007

Language	Label	Description	Also known as
English	Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251).	scientific article published on 29 September 2007

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251). (English)

1 reference

Europe PubMed Central

14 December 2017

Simian immunodeficiency virus

0 references

1 reference

based on heuristic

inferred from title

Marjorie Robert-Guroff

13

object named as

Marjorie Robert-Guroff

1 reference

Europe PubMed Central

14 December 2017

author name string

Qifeng Zhou

1

1 reference

Europe PubMed Central

14 December 2017

Rachmat Hidajat

2

1 reference

Europe PubMed Central

14 December 2017

Bo Peng

3

1 reference

Europe PubMed Central

14 December 2017

David Venzon

4

1 reference

Europe PubMed Central

14 December 2017

M Kristine Aldrich

5

1 reference

Europe PubMed Central

14 December 2017

Ersell Richardson

6

1 reference

Europe PubMed Central

14 December 2017

Eun Mi Lee

7

1 reference

Europe PubMed Central

14 December 2017

V S Kalyanaraman

8

1 reference

Europe PubMed Central

14 December 2017

George Grimes

9

1 reference

Europe PubMed Central

14 December 2017

V Raúl Gómez-Román

10

1 reference

Europe PubMed Central

14 December 2017

L Ebonita Summers

11

1 reference

Europe PubMed Central

14 December 2017

Nina Malkevich

12

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

29 September 2007

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

25

1 reference

Europe PubMed Central

14 December 2017

47

1 reference

Europe PubMed Central

14 December 2017

8021-8035

1 reference

Europe PubMed Central

14 December 2017

Immunologic correlates of protection induced by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Progress in the development of an HIV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Development of formulations that enhance physical stability of viral vectors for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Development and homeostasis of T cell memory in rhesus macaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Protective immunity towards intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Central memory and effector memory T cell subsets: function, generation, and maintenance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in M

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Intranasal delivery of vaccines against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Adenovirus vaccines in the U.S. military

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.09.017

1 reference

Europe PubMed Central

14 December 2017

release_omelewucizb5pfjdejtlwui2bi

1 reference

https://api.fatcat.wiki/v0/release/omelewucizb5pfjdejtlwui2bi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45399692&oldid=1844493299"